What is MoonLake Immunotherapeutics's interest coverage?

MoonLake Immunotherapeutics (MLTX) reported interest coverage of -28.2× in Q1 2026.

How has MoonLake Immunotherapeutics's interest coverage changed year-over-year?

MoonLake Immunotherapeutics's interest coverage increased by 99.7% year-over-year, from -9,486.4× to -28.2×.

What does interest coverage mean?

Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.

MoonLake Immunotherapeutics MLTX Interest coverage

Interest coverage at other companies

Oruka Therapeutics, Inc.ORKA

-49.7×—

Aurinia PharmaceuticalsAUPH

29.1×+22.5×

Arcutis Biotherapeutics, Inc.ARQT

-2.6×-1.0×

ImmunityBio, Inc.IBRX

-5×-1.1×

Immunovant, Inc.IMVT

-19×+5.0×

Johnson & JohnsonJNJ

24.5×-1.7×

Other financials

Income statement

See full

Operating income-$70.0M-47.5%

Net income-$69.7M-74.5%

EPS (diluted)-$0.98-55.6%

Balance sheet

See full

Cash & equivalents$298.5M+9.9%

Total debt$100.8M+33.3%

Total equity$254.0M-37.7%

Total assets$400.4M-21.7%

Cash flow

See full

Operating cash flow-$66.3M-73.8%

CapEx--100%

Free cash flow-$66.3M-73.6%

Valuation

See full

Market cap$1.49B-45.9%

Returns & leverage

See full

Return on equity-77.7%-221pp

Debt / equity0.4×+0.2×

Current ratio8.6×-12.5×

Where this comes from

Calculated from MoonLake Immunotherapeutics’s reported figures.

ebit/interest expense=-28.2×

Based on trailing twelve months.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MoonLake Immunotherapeutics's interest coverage?: MoonLake Immunotherapeutics (MLTX) reported interest coverage of -28.2× in Q1 2026.
How has MoonLake Immunotherapeutics's interest coverage changed year-over-year?: MoonLake Immunotherapeutics's interest coverage increased by 99.7% year-over-year, from -9,486.4× to -28.2×.
What does interest coverage mean?: Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.